ARTICLE | Clinical News
NPC-1C ELISA diagnostic data
January 24, 2011 8:00 AM UTC
An analysis of serum samples from 41 patients with colorectal or pancreatic cancer and 28 healthy controls showed that Neogenix's NPC-1C ELISA had 82% sensitivity and 71% specificity for detecting can...